Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Additional Information (Details)

v3.22.1
Financial Instruments - Additional Information (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Dec. 08, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Marketable equity securities $ 19,051    
Gross unrealized loss 954    
Contingent consideration, liability (up to) 2,768    
Investments in privately held entities $ 8,300 $ 5,000  
Company X | Contingent Consideration - Company X      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration, liability (up to)     $ 3,000